A critical advance in cancer study is occurring with the use of VHH fragments to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in many forms of cancer, causing uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research